Sign in
(97) - A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation
Journal article   Peer reviewed

(97) - A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation

A. Iacono, M. Terrin, K. Rajakopal, J. McGrain, E. Barr, J. Rinaldi, A. Patel, I. Timofte, J. Kim, Z. Kon, …
The Journal of heart and lung transplantation, Vol.35(4), pp.S44-S45
2016-04

Metrics

1 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.157 Organ Donation & Transplantation
1.157.1089 Lung Transplantation
Web Of Science research areas
Cardiac & Cardiovascular Systems
Respiratory System
Surgery
Transplantation
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details